Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Puerto Rico Technology Today.
Press releases published on July 22, 2025
XORTX Completes Non-Brokered Private Placement of Units
Not For Distribution to United States News Wire Services or for Dissemination in the United States CALGARY, Alberta, July 22, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late- …
iDox.ai Announces Launch of iDox.ai Privacy Scout: AI-Powered Solution That Goes Beyond DLP to Protect Sensitive Data in Real Time
Fremont, California , July 22, 2025 (GLOBE NEWSWIRE) -- iDox.ai, a U.S.-based provider of AI-powered document compliance tools, announces the launch of iDox.ai Privacy Scout, an advanced Data Loss Prevention (DLP) solution engineered to detect and protect …
Eupraxia Pharmaceuticals Invited to Present at Upcoming Investor Conferences
VICTORIA, British Columbia, July 22, 2025 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary DiffuSphere™ technology designed to …
Stride Announces Date for Fourth Quarter Fiscal Year 2025 Earnings Call
RESTON, VA, July 22, 2025 (GLOBE NEWSWIRE) -- Stride Inc. (NYSE: LRN) announced today it plans to discuss its fourth quarter and full fiscal year 2025 financial results during a conference call scheduled for Tuesday, August 5, 2025 at 5:00 p.m. eastern …
SciChart gewinnt den Preis „Gesundheitstechnologie des Jahres” bei den National Technology Awards 2025
LONDON, July 22, 2025 (GLOBE NEWSWIRE) -- SciChart, der weltweit führende Anbieter von leistungsstarker Software für Diagramme und Datenvisualisierung, ist bei den 2025 National Technology Awards – einer der renommiertesten Auszeichnungen für …
Intuitive Machines Announces Date for Second Quarter 2025 Financial Results Conference Call
HOUSTON, July 22, 2025 (GLOBE NEWSWIRE) -- Intuitive Machines, Inc. (Nasdaq: LUNR) (“Intuitive Machines”) (“Company”) announced today that it will release its financial results for the second quarter of 2025 on Thursday, August 7, 2025, before the market …
Supernus Pharmaceuticals to Announce Second Quarter 2025 Financial Results and Host Conference Call and Webcast on August 5, 2025
ROCKVILLE, Md., July 22, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that …
DBV Technologies Announces Appointment of James Briggs as Chief Human Resources Officer
Châtillon, France, July 22, 2025 DBV Technologies Announces Appointment of James Briggs as Chief Human Resources Officer DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Market: DBVT), a clinical-stage biopharmaceutical company, today …
DBV Technologies annonce la nomination de James Briggs au poste de Directeur des Ressources Humaines
Châtillon, France, le 22 juillet (22 :30 CEST) 2025 DBV Technologies annonce la nomination de James Briggs au poste de Directeur des Ressources Humaines DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT— CUSIP: 23306J309), …
BlackLine Announces Date for Second Quarter 2025 Earnings Release and Conference Call
LOS ANGELES, July 22, 2025 (GLOBE NEWSWIRE) -- BlackLine, Inc. (Nasdaq: BL) announced today that it will release financial results for the second quarter ended June 30, 2025 after market close on Tuesday, August 5, 2025 followed by a conference call hosted …
Seer to Report Second Quarter 2025 Financial Results on August 6, 2025
REDWOOD CITY, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that it will report financial results for the second quarter 2025 on Wednesday, August …
Abivax Announces Positive Phase 3 Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod, its First-in-Class Oral miR-124 Enhancer, in Moderate to Severely Active Ulcerative Colitis
Abivax Announces Positive Phase 3 Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod, its First-in-Class Oral miR-124 Enhancer, in Moderate to Severely Active Ulcerative Colitis 50 mg once-daily dose of obefazimod led to a …
Rigetti Computing to Report Second Quarter 2025 Financial Results and Host Conference Call on August 12, 2025
BERKELEY, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Rigetti Computing, Inc. ("Rigetti" or the "Company") (Nasdaq: RGTI), a pioneer in hybrid quantum-classical computing, announced today that it will release second quarter 2025 results on August 12, 2025 …
NextNav Announces Date for Second Quarter 2025 Earnings Call
RESTON, Va., July 22, 2025 (GLOBE NEWSWIRE) -- NextNav (Nasdaq: NN), a leader in next generation positioning, navigation, timing (PNT) and 3D geolocation, today announced that it will release its financial results for the second quarter ended June 30, 2025 …
Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2025 Financial Results on August 7, 2025
CANTON, Mass., July 22, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and …
electroCore to Participate in Upcoming Investor Conferences
ROCKAWAY, N.J., July 22, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate in the following investor conferences. Needham 10th Annual …
Pharvaris Announces Proposed Public Offering of Ordinary Shares
ZUG, Switzerland, July 22, 2025 (GLOBE NEWSWIRE) -- Pharvaris N.V. (“Pharvaris,” Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to address unmet needs of those living with bradykinin-mediated …
Rhythm Pharmaceuticals to Report Second Quarter 2025 Financial Results on Tuesday, August 5, 2025
BOSTON, July 22, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that it will …
$1R0R Launches on Major Exchanges as R0AR Team Drives True DeFi Ownership
Sheridan, WY, July 22, 2025 (GLOBE NEWSWIRE) -- R0AR has announced the listing of its $1R0R token on prominent exchanges MEXC and BitMart, marking a significant step toward making DeFi as accessible and secure as traditional banking while preserving user …
OZ Studio, a Global Firm with Texas Roots, Showcases Ethical AI Governance Model at the United Nations
VIENNA, AUSTRIA , July 22, 2025 (GLOBE NEWSWIRE) -- OZ Studio, a global technology firm with offices in Austin, Texas; Geneva, Switzerland; and Monterrey, Mexico, presented a groundbreaking model for municipal governance and ethical artificial intelligence …